FDA 483 - OMRIX Biopharmaceuticals LTD - February 16, 2020
FDA 483 for OMRIX Biopharmaceuticals LTD on February 16, 2020. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for OMRIX Biopharmaceuticals LTD on February 16, 2020. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
OMRIX Biopharmaceuticals LTDInspection Date
February 16, 2020
Product Type
biologics
ID: 95c3cca2-bbf4-4923-8eaf-627f601c7a13
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox